Top Suppliers:I want be here



145667-75-0

145667-75-0 structure
145667-75-0 structure
  • Name: Latanoprost lactone diol
  • Chemical Name: (3aR,4R,5R,6aS)-5-hydroxy-4-[(3R)-3-hydroxy-5-phenylpentyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one
  • CAS Number: 145667-75-0
  • Molecular Formula: C18H24O4
  • Molecular Weight: 304.381
  • Catalog: Signaling Pathways GPCR/G Protein Prostaglandin Receptor
  • Create Date: 2018-08-19 07:54:16
  • Modify Date: 2024-01-03 12:30:57
  • Latanoprost lactone diol is an intermediate in the synthesis of Latanoprost. Latanoprost is a prostaglandin F2α analogue and an agonist for the FP prostanoid receptor, and lowers intraocular-pressure (IOP)[1].

Name (3aR,4R,5R,6aS)-5-hydroxy-4-[(3R)-3-hydroxy-5-phenylpentyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one
Synonyms (3aR,4R,5R,6aS)-5-Hydroxy-4-[(3R)-3-hydroxy-5-phenylpentyl]hexahydro-2H-cyclopenta[b]furan-2-one
LatanoprostLactoneDiol
2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(3R)-3-hydroxy-5-phenylpentyl]-, (3aR,4R,5R,6aS)-
Description Latanoprost lactone diol is an intermediate in the synthesis of Latanoprost. Latanoprost is a prostaglandin F2α analogue and an agonist for the FP prostanoid receptor, and lowers intraocular-pressure (IOP)[1].
Related Catalog
References

[1]. Pauly A, et al. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation. Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8172-80.

Density 1.2±0.1 g/cm3
Boiling Point 523.0±35.0 °C at 760 mmHg
Melting Point 69-71ºC
Molecular Formula C18H24O4
Molecular Weight 304.381
Flash Point 190.3±19.4 °C
Exact Mass 304.167450
PSA 66.76000
LogP 0.60
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.568

~79%

145667-75-0 structure

145667-75-0

Literature: Chirogate International Inc. Patent: EP1810967 A1, 2007 ; Location in patent: Page/Page column 20-21 ;

~85%

145667-75-0 structure

145667-75-0

Literature: Resul, Bahram; Stjernschantz, Johan; No, Kiyo; Liljebris, Charlotta; Selen, Goeran; et al. Journal of Medicinal Chemistry, 1993 , vol. 36, # 2 p. 243 - 248

~%

145667-75-0 structure

145667-75-0

Literature: EP1886992 A1, ; Page/Page column 9 ;

~%

145667-75-0 structure

145667-75-0

Literature: Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248

~%

145667-75-0 structure

145667-75-0

Literature: Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248

~%

145667-75-0 structure

145667-75-0

Literature: Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248

~%

145667-75-0 structure

145667-75-0

Literature: Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248

~%

145667-75-0 structure

145667-75-0

Literature: Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248